Daily single-stock coverage from some of investing's top-rated writers. Actionable ideas, focused to help you make money.
QBTS stock isn't the dip-buying opportunity you think it is
Contributor Will Ashworth checks in with the final three stocks that he will cover in the coming months (unless NHL games distract him)
TSX Venture stocks come into focus as contributor Will Ashworth sets out his 2025 follow list
Attractive entry point just one of the reasons for risk-tolerant growth investors to look closely at PDYN stock.
SPOT stock is likely to extend its three-figure rally into the new year as the entertainment stock benefits from subscription growth and market leadership
While 2024 has been a good year for investors in Toronto-listed stocks, contributor Will Ashworth writes there are a few that he missed
The nomination of FDA critic RFK Jr. has cast a cloud over the biotech sector
His easiest way to make good on the campaign pledge to double America’s electricity capacity is from the biggest renewable source in the sky
PLTR stock is pricey but still deserves careful consideration
You don’t have to be a Drake fan to see that for UPST stock, the proof is in the progress
